Companies Cryptocurrencies
Odonate Therapeutics Inc
Odonate Therapeutics Inc
Exchange: Nasdaq Global Select
IPO Date: 07/12/2017
CEO: Mr. Kevin Tang
Biotechnology Healthcare 🔗
  • ODT
  • 1.12
  • 43109136
    market cap
  • -0.04999995
If you bought

shares of Odonate Therapeutics Inc (ODT) on
You would have made
Old Price $12 Current Price $12

Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. The company is headquartered in San Diego, California and currently employs 117 full-time employees. The firm is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company is focused on the development of tesetaxel, a novel chemotherapy agent. The company has completed Phase-II studies in patients with metastatic breast cancer (MBC). The firm’s tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).

Address: 4747 Executive Dr Ste 510 San Diego CALIFORNIA 92121

Stay updated.